Affiliation:
1. V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology
Abstract
Currently, there are numerous anticonvulsants with a favorable pharmacological profile and high safety are available. However, there is still a risk of drug-induced adverse events during long-term administration of antiepileptic therapy. One of the most unfavorable changes in bone tissue associated with anticonvulsant use is osteoporotic disorders, which result in a loss of bone density, making the bones more fragile and prone to fractures. The problem of decreased bone mineral density and frequent fractures in patients with epilepsy is an important and understudied issue that significantly reduces quality of life and involves significant economic costs for the treatment and rehabilitation of epileptic patients. Studying the interaction between osteoporosis and epilepsy is of great importance for the development of effective methods for timely diagnosis, treatment and prevention of bone metabolism disorders. This article presents pilot results of a study to investigate the effect of antiepileptic therapy on mineral metabolism and bone density. The aim of the study: to evaluate bone mineral density in adult patients with epilepsy long-term receiving antiepileptic therapy. Materials and methods. Thirty-eight adult patients with epilepsy taking antiepileptic drugs for a long time were examined. All patients underwent general clinical, neurologic examination and densitometric study by quantitative computed tomography at three points (L1, L2 and femoral neck). Results. Decreased bone mineral density was found in 34.2% of the patients. Of them, 29% had osteopenia and 5.2% - osteoporosis. The change in mineral density was observed at a median duration of antiepileptic therapy of 8 years. ROC analysis showed that bone mineral density decreased statistically significantly with increasing duration of anitconvulsant therapy (SROC 0.929±0.052; 95% CI: 0.827-1.000). Correlation analysis revealed a markedly close association (ρ = -0.626, p < 0.001) between bone mineral density and duration of antiepileptic therapy. Conclusion. The results of the study confirm the effect of antiepileptic therapy on bone mineral density. And show that the probability of developing osteopenia and osteoprosis with longer duration of anticonvulsant therapy is higher than in the general population. The study of the effects of antiepileptic drugs on bone metabolism has important clinical implications for effective strategies for prescribing antiepileptic therapy in epileptic patients and requires further research.
Publisher
V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology
Reference28 articles.
1. Belaya ZE, Belova KYu, Biryukova EV, Dedov II, Dzeranova LK, Drapkina OM, Dreval AV, Dubovitskaya TA, Dudinskaya EN, Ershova OB et al. Federal clinical guidelines for diagnosis, treatment and prevention of osteoporosis. Osteoporoz i osteopatii. 2021;24(2):4-47. (In Russ.). https://doi.org/10.14341/osteo12930
2. Zhidkova IA, Kaznacheeva TV, Demidova EYu, Berseneva VV. Molecular mechanisms responsible for the impact of antiepileptic therapy on bone mineral density of epileptic patients. Nevrologiya, neiropsihiatriya, psihosomatika. 2016;(Special Issue 1):59–65. http://dx.doi.org/10.14412/2074-2711-2016-1S-59-65 (In Russ.).
3. Zasedateleva IYu. Mineral metabolism disorders in patients with epilepsy. Uchenyye zapiski. 2005;12(1):43-44 (In Russ.).
4. Zakharov IS. Imaging diagnosis of osteoporosis – current state of problems. Politravma. 2015;(1):69-73 (in Russ.).
5. Zakharov IS. Estimation of consistency of results of different methods of bone densitometry in diagnostics of osteoporosis in women. Politravma 2015;2:59-63. (in Russ.).